{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:40:12Z","timestamp":1789980012537,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1236-y","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T13:04:10Z","timestamp":1549458250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4540-125X","authenticated-orcid":false,"given":"Shinya","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Koshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoya","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"1236_CR1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1681\/ASN.2015111262","volume":"28","author":"DC Cattran","year":"2017","unstructured":"Cattran DC, Kim ED, Reich H, Hladunewich M, Kim SJ. Toronto glomerulonephritis registry group and for the TGR. Membranous nephropathy: quantifying remission duration on outcome. J Am Soc Nephrol. 2017;28:995\u20131003.","journal-title":"J Am Soc Nephrol"},{"key":"1236_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2215\/CJN.04160413","volume":"9","author":"C Ponticelli","year":"2014","unstructured":"Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy--a modern view. Clin J Am Soc Nephrol. 2014;9:609\u201316.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1236_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck","year":"2009","unstructured":"Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A 2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11\u201321.","journal-title":"N Engl J Med"},{"key":"1236_CR4","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas NM, Beck LH, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al. Thrombospondin Type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014;371:2277\u201387.","journal-title":"N Engl J Med"},{"key":"1236_CR5","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1093\/ndt\/gfr247","volume":"26","author":"E Hoxha","year":"2011","unstructured":"Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26:2526\u201332.","journal-title":"Nephrol Dial Transplant"},{"key":"1236_CR6","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.2215\/CJN.03850414","volume":"9","author":"E Hoxha","year":"2014","unstructured":"Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RAK. M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clin J Am Soc Nephrol. 2014;9:1883\u201390.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1236_CR7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.2215\/CJN.07210810","volume":"6","author":"JM Hofstra","year":"2011","unstructured":"Hofstra JM, Beck LH, Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6:1286\u201391.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1236_CR8","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMc1511702","volume":"374","author":"E Hoxha","year":"2016","unstructured":"Hoxha E, Wiech T, Stahl PR, Zahner G, Tomas NM, Meyer-Schwesinger C, et al. A mechanism for Cancer-associated membranous nephropathy. N Engl J Med. 2016;374:1995\u20136.","journal-title":"N Engl J Med"},{"key":"1236_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2016010050","volume":"28","author":"E Hoxha","year":"2017","unstructured":"Hoxha E, Beck LH, Wiech T, Tomas NM, Probst C, Mindorf S, et al. An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy. J Am Soc Nephrol. 2017;28:520\u201331.","journal-title":"J Am Soc Nephrol"},{"key":"1236_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7326\/0003-4819-64-1-41","volume":"64","author":"JC LEE","year":"1966","unstructured":"LEE JC, YAMAUCHI H, HOPPER J. The Association of Cancer and the nephrotic syndrome. Ann Intern Med. 1966;64:41\u201351.","journal-title":"Ann Intern Med"},{"key":"1236_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000364782","volume":"40","author":"N Leeaphorn","year":"2014","unstructured":"Leeaphorn N, Kue-A-Pai P, Thamcharoen N, Ungprasert P, Stokes MB, Knight EL. Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies. Am J Nephrol. 2014;40:29\u201335.","journal-title":"Am J Nephrol"},{"key":"1236_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/gcc.22440","volume":"56","author":"PR Stahl","year":"2017","unstructured":"Stahl PR, Hoxha E, Wiech T, Schr\u00f6der C, Simon R, Stahl RAK. THSD7A expression in human cancer. Genes Chromosom Cancer. 2017;56:314\u201327.","journal-title":"Genes Chromosom Cancer"},{"key":"1236_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0270-9295(03)00055-X","volume":"23","author":"JA Jefferson","year":"2003","unstructured":"Jefferson JA, Couser WG. Therapy of membranous nephropathy associated with malignancy and secondary causes. Semin Nephrol. 2003;23:400\u20135.","journal-title":"Semin Nephrol"},{"key":"1236_CR14","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1073\/pnas.79.18.5557","volume":"79","author":"D Kerjaschki","year":"1982","unstructured":"Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A. 1982;79:5557\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1236_CR15","first-page":"163","volume":"23","author":"D Kerjaschki","year":"2000","unstructured":"Kerjaschki D. Megalin\/GP330 and pathogenetic concepts of membranous glomerulopathy (MGN). Kidney Blood Press Res. 2000;23:163\u20136.","journal-title":"Kidney Blood Press Res"},{"key":"1236_CR16","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMoa012895","volume":"346","author":"H Debiec","year":"2002","unstructured":"Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann J-P, Bensman A, et al. Antenatal membranous glomerulonephritis due to anti\u2013neutral endopeptidase antibodies. N Engl J Med. 2002;346:2053\u201360.","journal-title":"N Engl J Med"},{"key":"1236_CR17","doi-asserted-by":"publisher","first-page":"e0138841","DOI":"10.1371\/journal.pone.0138841","volume":"10","author":"T Iwakura","year":"2015","unstructured":"Iwakura T, Ohashi N, Kato A, Baba S, Yasuda H. Prevalence of enhanced granular expression of thrombospondin Type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy. PLoS One. 2015;10:e0138841.","journal-title":"PLoS One"},{"key":"1236_CR18","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.2215\/CJN.01460217","volume":"12","author":"J Wang","year":"2017","unstructured":"Wang J, Cui Z, Lu J, Probst C, Zhang Y, Wang X, et al. Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2017;12:1642\u201351.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1236_CR19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jcp.21990","volume":"222","author":"C-H Wang","year":"2009","unstructured":"Wang C-H, Su P-T, Du X-Y, Kuo M-W, Lin C-Y, Yang C-C, et al. Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation. J Cell Physiol. 2009;222:685\u201394.","journal-title":"J Cell Physiol"},{"key":"1236_CR20","doi-asserted-by":"publisher","first-page":"e29000","DOI":"10.1371\/journal.pone.0029000","volume":"6","author":"M-W Kuo","year":"2011","unstructured":"Kuo M-W, Wang C-H, Wu H-C, Chang S-J, Chuang Y-J. Soluble THSD7A Is an N-Glycoprotein That Promotes Endothelial Cell Migration and Tube Formation in Angiogenesis. PLoS One. 2011;6:e29000.","journal-title":"PLoS One"},{"key":"1236_CR21","unstructured":"Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res. 2000;6:2417\u201323."},{"key":"1236_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1369\/0022155414561498","volume":"63","author":"H Yoon","year":"2015","unstructured":"Yoon H, Dehart JP, Murphy JM, S-TS L. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights. J Histochem Cytochem. 2015;63:114\u201328.","journal-title":"J Histochem Cytochem"},{"key":"1236_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ki.1980.1","volume":"17","author":"WG Couser","year":"1980","unstructured":"Couser WG, Salant DJ. In situ immune complex formation and glomerular injury. Kidney Int. 1980;17:1\u201313.","journal-title":"Kidney Int"},{"key":"1236_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.semnephrol.2010.09.011","volume":"30","author":"LH Beck","year":"2010","unstructured":"Beck LH. Membranous nephropathy and malignancy. Semin Nephrol. 2010;30:635\u201344.","journal-title":"Semin Nephrol"},{"key":"1236_CR25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2010090967","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Beck LH, Zeng C, Chen Z, Li S, Zuo K, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22:1137\u201343.","journal-title":"J Am Soc Nephrol"},{"key":"1236_CR26","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/ndt\/gfr534","volume":"27","author":"Z Qu","year":"2012","unstructured":"Qu Z, Liu G, Li J, Wu L -h, Tan Y, Zheng X, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant. 2012;27:1931\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"1236_CR27","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ndt\/gfg616","volume":"19","author":"H Ohtani","year":"2004","unstructured":"Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"1236_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","volume":"56","author":"PM Ronco","year":"1999","unstructured":"Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355\u201377.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1236-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1236-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1236-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T15:45:18Z","timestamp":1720971918000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1236-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1236"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1236-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent has been obtained from the patient for publication of the case report and any companying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"43"}}